286079.fig.003a
(a)
286079.fig.003b
(b)
286079.fig.003c
(c)
286079.fig.003d
(d)
286079.fig.003e
(e)
286079.fig.003f
(f)
286079.fig.003g
(g)
286079.fig.003h
(h)
286079.fig.003i
(i)
286079.fig.003j
(j)
286079.fig.003k
(k)
286079.fig.003l
(l)
286079.fig.003m
(m)
286079.fig.003n
(n)
286079.fig.003o
(o)
286079.fig.003p
(p)
286079.fig.003q
(q)
286079.fig.003r
(r)
286079.fig.003s
(s)
286079.fig.003t
(t)
286079.fig.003u
(u)
286079.fig.003v
(v)
286079.fig.003w
(w)
286079.fig.003x
(x)
286079.fig.003y
(y)
286079.fig.003z
(z)
Figure 3: 24 h simulation of the venous blood concentration following inhalation exposure to 1 ppm, 8 h for 26 volatile organic compounds considering maximum and minimum (bold lines) and QPPR-based hepatic extraction (grey area). (a) 1,1,1,2-Tetrachloroethane; (b) 1,1,2,2-tetrachloroethane; (c) 1,1,2-trichloroethane; (d) 1,1-dichloroethane; (e) 1,1-dichloroethylene; (f) 1,2-dichloroethane; (g) 1,2-dichloroethylene (cis-); (h) benzene; (i) bromochloromethane; (j) bromodichloromethane; (k) carbon tetrachloride; (l) chloroethane; (m) chloroform; (n) dibromomethane; (o) dichloromethane; (p) ethylbenzene; (q) hexachloroethane; (r) isoprene; (s) methyl chloride; (t) m-xylene; (u) n-hexane; (v) pentachloroethane; (w) styrene; (x) toluene; (y) trichloroethylene; (z) vinyl chloride.